Intrahepatic Bile Ducts Develop According to a New Mode of Tubulogenesis Regulated by the Transcription Factor SOX9

Université catholique de Louvain, de Duve Institute, Brussels, Belgium.
Gastroenterology (Impact Factor: 16.72). 02/2009; 136(7):2325-33. DOI: 10.1053/j.gastro.2009.02.051
Source: PubMed


A number of diseases are characterized by defective formation of the intrahepatic bile ducts. In the embryo, hepatoblasts differentiate to cholangiocytes, which give rise to the bile ducts. Here, we investigated duct development in mouse liver and characterized the role of the SRY-related HMG box transcription factor 9 (SOX9).
We identified SOX9 as a new biliary marker and used it in immunostaining experiments to characterize bile duct morphogenesis. The expression of growth factors was determined by in situ hybridization and immunostaining, and their role was studied on cultured hepatoblasts. SOX9 function was investigated by phenotyping mice with a liver-specific inactivation of Sox9.
Biliary tubulogenesis started with formation of asymmetrical ductal structures, lined on the portal side by cholangiocytes and on the parenchymal side by hepatoblasts. When the ducts grew from the hilum to the periphery, the hepatoblasts lining the asymmetrical structures differentiated to cholangiocytes, thereby allowing formation of symmetrical ducts lined only by cholangiocytes. We also provide evidence that transforming growth factor-beta promotes differentiation of the hepatoblasts lining the asymmetrical structures. In the absence of SOX9, the maturation of asymmetrical structures into symmetrical ducts was delayed. This was associated with abnormal expression of CCAAT/Enhancer Binding Protein alpha and Homolog of Hairy/Enhancer of Split-1, as well as of the transforming growth factor-beta receptor type II, which are regulators of biliary development.
Our results suggest that biliary development proceeds according to a new mode of tubulogenesis characterized by transient asymmetry and whose timing is controlled by SOX9.

Download full-text


Available from: Frédéric Clotman,

Click to see the full-text of:

Article: Intrahepatic Bile Ducts Develop According to a New Mode of Tubulogenesis Regulated by the Transcription Factor SOX9

3.93 MB

See full-text
  • Source
    • "It was found that GATA6, a transcription factor that plays an important role during embryonic liver development (Si-Tayeb et al., 2010), is highly expressed in hWJs. Other transcription factors involved in liver development, including GATA4, which is critical for endodermal development (Bossard and Zaret, 1998), SOX9, a transcription factor that determines the timing of bile duct development (Antoniou et al., 2009) and SOX17, a key transcription factor necessary for the normal development of the definitive endoderm (Okada et al., 2011) are also significantly expressed in hWJs. FOXA2, necessary for liver development initiation (Kaestner, 2005), and ONECUT1 which plays an important role in hepatoblast migration (Margagliotti et al., 2007), are, however, not expressed at all in hWJs. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Stem cell technology could offer a unique tool to develop human-based in vitro liver models that are applicable for testing of potential liver toxicity early during drug development. In this context, recent research has indicated that human Wharton's Jelly-derived mesenchymal stem cells (hWJs) represent an interesting stem cell population to develop human hepatocyte-like cells. Here, an in-depth analysis of the expression of liver-specific transcription factors and other key hepatic markers in hWJs is evaluated at both the mRNA and protein level. Our results reveal that transcription factors that are mandatory to acquire and maintain an adult hepatic phenotype (HNF4A and HNF1A), as well as adult hepatic markers (ALB, CX32, CYP1A1, CYP1A2, CYP2B6 and CYP3A4) are not expressed in hWJs with the exception of K18. On the contrary, transcription factors involved in liver development (GATA4, GATA6, SOX9 and SOX17) and liver progenitor markers (DKK1, DPP4, DSG2, CX43 and K19) were found to be highly expressed in hWJs. These findings provide additional indication that hWJs could be a promising stem cell source to generate hepatocyte-like cells necessary for the development of a functional human-based in vitro liver model.
    Toxicology in Vitro 02/2014; 28(1):113-119. DOI:10.1016/j.tiv.2013.06.014 · 2.90 Impact Factor
  • Source
    • "Choline acetyltransferase and Vesicular Acetylcholine Transferase riboprobes were provided by Dr. Ernsberger [40], Neuregulin-1 and Neuregulin-2 by Dr. C. Lai [41] and TGF-ß Receptor II by Dr. F. Lemaigre [42]. The Agrin riboprobe corresponded to nucleotides 6327–6840 of the NM_021604.3 "
    [Show abstract] [Hide abstract]
    ABSTRACT: The neuromuscular junctions are the specialized synapses whereby spinal motor neurons control the contraction of skeletal muscles. The formation of the neuromuscular junctions is controlled by a complex interplay of multiple mechanisms coordinately activated in motor nerve terminals and in their target myotubes. However, the transcriptional regulators that control in motor neurons the genetic programs involved in neuromuscular junction development remain unknown. Here, we provide evidence that the Onecut transcription factor HNF-6 regulates in motor neurons the formation of the neuromuscular junctions. Indeed, adult Hnf6 mutant mice exhibit hindlimb muscle weakness and abnormal locomotion. This results from defects of hindlimb neuromuscular junctions characterized by an abnormal morphology and defective localization of the synaptic vesicle protein synaptophysin at the motor nerve terminals. These defects are consequences of altered and delayed formation of the neuromuscular junctions in newborn mutant animals. Furthermore, we show that the expression level of numerous regulators of neuromuscular junction formation, namely agrin, neuregulin-2 and TGF-ß receptor II, is downregulated in the spinal motor neurons of Hnf6 mutant newborn animals. Finally, altered formation of neuromuscular junction-like structures in a co-culture model of wildtype myotubes with mutant embryonic spinal cord slices is rescued by recombinant agrin and neuregulin, indicating that depletion in these factors contributes to defective neuromuscular junction development in the absence of HNF-6. Thus, HNF-6 controls in spinal motor neurons a genetic program that coordinates the formation of hindlimb neuromuscular junctions.
    PLoS ONE 12/2012; 7(12):e50509. DOI:10.1371/journal.pone.0050509 · 3.23 Impact Factor
  • Source
    • "In mouse, a link between Sox9 and Notch in biliary development has been suggested based on the observation of the expression pattern of Hes1, a mediator of Notch signalling, is affected in Sox9 hepatic knockout (Antoniou et al., 2009). In zebrafish, it is not clear whether sox9b and Notch signalling cooperate in IHD morphogenesis as (i) Notch appears to regulate more aspects of duct remodelling than sox9b and (ii) sox9b is still well expressed in the IHD following DAPT treatment (data not shown). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Recent zebrafish studies have shown that the late appearing pancreatic endocrine cells are derived from pancreatic ducts but the regulatory factors involved are still largely unknown. Here, we show that the zebrafish sox9b gene is expressed in pancreatic ducts where it labels the pancreatic Notch-responsive cells previously shown to be progenitors. Inactivation of sox9b disturbs duct formation and impairs regeneration of beta cells from these ducts in larvae. sox9b expression in the midtrunk endoderm appears at the junction of the hepatic and ventral pancreatic buds and, by the end of embryogenesis, labels the hepatopancreatic ductal system as well as the intrapancreatic and intrahepatic ducts. Ductal morphogenesis and differentiation are specifically disrupted in sox9b mutants, with the dysmorphic hepatopancreatic ducts containing misdifferentiated hepatocyte-like and pancreatic-like cells. We also show that maintenance of sox9b expression in the extrapancreatic and intrapancreatic ducts requires FGF and Notch activity, respectively, both pathways known to prevent excessive endocrine differentiation in these ducts. Furthermore, beta cell recovery after specific ablation is severely compromised in sox9b mutant larvae. Our data position sox9b as a key player in the generation of secondary endocrine cells deriving from pancreatic ducts in zebrafish.
    Developmental Biology 04/2012; 366(2):268-78. DOI:10.1016/j.ydbio.2012.04.002 · 3.55 Impact Factor
Show more